Artin M.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Efficacy and Safety of MET097 in Adults with Overweight or Obesity: A Phase 3, Randomized, Placebo-Controlled Trial
- Phase 3 Randomized, Placebo‑Controlled Trial Assessing Efficacy and Safety of MET097, a Long‑Acting GLP‑1 Receptor Agonist, in Overweight/Obese Adults with Type 2 Diabetes
- Phase 3 Study of KAI-9531 in Adults With Obesity or Overweight With Weight-Related Comorbidities Without Diabetes
Data & Insights
Has run more than one trial at 176 of 356 partner sites.
Specializations
Weight Management Expertise
This investigator specializes in obesity medicine and weight management therapies, conducting research on innovative approaches to weight reduction in individuals with overweight and obesity conditions.
- Weight Loss Interventions
- Obesity Treatment
- Metabolic Health
The investigator focuses on comprehensive weight management strategies combining medical interventions with lifestyle modifications.
Lifestyle Medicine
Expertise in integrating lifestyle interventions and behavioral modifications as part of weight management treatment protocols, including dietary approaches and physical activity programs.
- Dietary Interventions
- Physical Activity Programs
- Behavioral Modification
The research incorporates evidence-based lifestyle modifications to enhance weight management outcomes.
Therapeutic Innovation
Active involvement in evaluating novel weight management therapies and their effectiveness in treating obesity when combined with lifestyle interventions.
- Novel Therapeutic Approaches
- Combined Treatment Strategies
- Clinical Outcomes Assessment
The investigator examines innovative therapeutic solutions for addressing obesity and overweight conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.